Terumo BCT is a global leader in blood component and cellular technologies, serving customers in 120 countries and territories. As the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing, we believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers. Terumo BCT Viet Nam (TBV) came into operation in 2014 with American and Japanese investment Corporation, and right now we have more than 1,300 associates at Vietnam site. www.terumobct.com